Inhibition of human herpesvirus 6 replication by 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine (2HM-HBG) and other antiviral compounds
- 1 December 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (12) , 2417-2419
- https://doi.org/10.1128/aac.34.12.2417
Abstract
The in vitro susceptibilities of human herpesvirus 6 to foscarnet; the guanosine analogs acyclovir, ganciclovir, and two isomers of 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine; and the thymidine analogs 3'-azido-3'-deoxythymidine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil were investigated. All compounds except 3'-azido-3'-deoxythymidine and 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil inhibited human herpesvirus 6 replication. The highest in vitro selectivity was obtained for 9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine.This publication has 20 references indexed in Scilit:
- Phosphonoacetic acid inhibits replication of human herpesvirus-6Antiviral Research, 1989
- SUSCEPTIBILITY OF HUMAN HERPESVIRUS 6 TO ACYCLOVIRThe Lancet, 1989
- SUSCEPTIBILITY OF HUMAN HERPESVIRUS 6 TO ACYCLOVIR AND GANCICLOVIRThe Lancet, 1989
- In vitro sensitivity of human herpesvirus-6 to antiviral drugsResearch in Virology, 1989
- Antiviral effects of phosphonoformate (pfa, foscarnet sodium)Pharmacology & Therapeutics, 1989
- Human herpes virus type 6 (HHV-6) and its in vitro effect on human immunodeficiency virus (HIV).Journal of Clinical Pathology, 1988
- Human B-lymphotropic virus (human herpesvirus-6)Journal of Virological Methods, 1988
- Human herpesvirus-6 (HHV-6, HBLV) in sarcoidosis and lymphoproliferative disordersJournal of Virological Methods, 1988
- IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUMPublished by Elsevier ,1988
- Isolation of a New Virus, HBLV, in Patients with Lymphoproliferative DisordersScience, 1986